cryo transmission electron microscopy (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
99
Structured Review
Thermo Fisher
cryo transmission electron microscopy
Cryo Transmission Electron Microscopy, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cryo+transmission+electron+microscopy/SUCROSE+EP%2FBP%2FNF+12KG/pm41664311-40-11-14
Average 99 stars, based on 1 article reviews
Cryo Transmission Electron Microscopy, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cryo+transmission+electron+microscopy/SUCROSE+EP%2FBP%2FNF+12KG/pm41664311-40-11-14
Average 99 stars, based on 1 article reviews
cryo transmission electron microscopy - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Synthesized:Article Title: NIR Emissive Biomimetic Ghost Nanovesicles for Site-Selective Solid Tumor Imaging Article Snippet: .. Synthesized nanoparticles were characterized through Electron Microscopy:Article Title: NIR Emissive Biomimetic Ghost Nanovesicles for Site-Selective Solid Tumor Imaging Article Snippet: .. Synthesized nanoparticles were characterized through Article Title: Nanoscale Colloids Engineering for Minimizing Efficiency Loss in Scalable Perovskite Solar Cells. Article Snippet: .. The morphology and size of perovskite colloids were further investigated by Article Title: Extracellular vesicles of iPS cells highly capable of producing HGF and TGF-β1 can attenuate Sjögren's syndrome via innate immunity regulation. Article Snippet: Previous studies have demonstrated that extracellular vesicles (EVs) from dental pulp stem cells (DPSCs), which release abundant hepatocyte growth factor (HGF) and transforming growth factor-β1 (TGF-β1), contribute to the pathogenesis of Sjögren’s syndrome (SS).. However, depending on the condition of DPSCs, this effect is often not achieved.. In this study, we established induced pluripotent stem (iPS) cells highly capable of releasing HGF and TGF-β1 and iPS cells barely capable of releasing them, and administered each EV to SS model mice to see if there was a difference in therapeutic effect. Article Title: A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Article Snippet: .. Characterization of surface morphology and internal structure were determined by Field Emission Scanning Electron Microscopy (FESEM, KYKY-EM3200–30KV, China), Control:Article Title: Nanoscale Colloids Engineering for Minimizing Efficiency Loss in Scalable Perovskite Solar Cells. Article Snippet: .. The morphology and size of perovskite colloids were further investigated by Isolation:Article Title: Extracellular vesicles of iPS cells highly capable of producing HGF and TGF-β1 can attenuate Sjögren's syndrome via innate immunity regulation. Article Snippet: Previous studies have demonstrated that extracellular vesicles (EVs) from dental pulp stem cells (DPSCs), which release abundant hepatocyte growth factor (HGF) and transforming growth factor-β1 (TGF-β1), contribute to the pathogenesis of Sjögren’s syndrome (SS).. However, depending on the condition of DPSCs, this effect is often not achieved.. In this study, we established induced pluripotent stem (iPS) cells highly capable of releasing HGF and TGF-β1 and iPS cells barely capable of releasing them, and administered each EV to SS model mice to see if there was a difference in therapeutic effect. |
![<t>(A)</t> <t>Cryo-TEM</t> images of MGS encapsulated in CDNP_PEG_4. The scale bar is 200 nm. (B) The scale bar is 50 nm. SAXS measurement of CDNP with Encapsulated MGS. (C) Comparison of SAXS profiles with and without MGS encapsulation in CDNP_PEGs and CDNP_ECH with MGS encapsulation. (D) SAXS results with different feeding concentration of MGS. Change in drug encapsulation ratio in (E) and [MGS]/[CD] in (F) as a function of MGS concentration. (G) Relationship between CD density ratio and [MGS]/[CD] in particles. (H) The mechanism of structural changes anticipated with drug encapsulation. Data are presented from a single experiment ( n = 1).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7803/pmc13087803/pmc13087803__bg5c00220_0003.jpg)